How One Company Is Mining Big Data to Fight Diabetes Glooko's diabetes-management platform allows patients and doctors more information, and investors are interested.
By Brittany Shoot •
Opinions expressed by Entrepreneur contributors are their own.
There are 29 million people living with diabetes in the U.S.—more than 9 percent of the population—at an annual cost of $245 billion. Even with an array of devices and drugs available to manage the condition, diabetes is the seventh-leading cause of death in the country.
Rick Altinger, CEO of Palo Alto, Calif.-based Glooko, calls it an unnecessary pandemic. "Properly controlled, with the technology and devices we have today, you can live a healthy life," he explains. "You don't need to die from diabetes."
Memorial Day Sale - Save 20%! Unlock this premium article & so much more with Entrepreneur+
Join the internet’s leading entrepreneur community with our Memorial Day sale! With your subscription, you'll get:
- Digestible insight on how to be a better entrepreneur and leader
- Lessons for starting and growing a business from our expert network of CEOs and founders
- Meaningful content to help you make sharper decisions
- Business and life hacks to help you stay ahead of the curve
Use code SAVE20 at checkout.
